









Markets
/
Stocks
/
nasdaq-lsb
/

LakeShore Biopharma Co Ltd

LSB

0.627USD

-0.163-20.68%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

13.02MMarket Cap

--P/E TTM



LakeShore Biopharma Co Ltd

0.627

-0.163-20.68%

Overview Company Financials Analysis

Income Statement

Cash Flow Statement

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---149.40M

---145.83M

Net income from continuing operations

---258.94M

---174.52M

Operating gains losses

--102.49M

--19.93M

Deferred tax

---20.91M

---820.35K

Other non-cash items

--59.51M

--18.47M

Change in working capital

---43.75M

---2.04M

-Change in receivables

---14.44M

--28.34M

-Change in inventory

---48.14M

---38.12M

-Change in prepaid expenses

--17.15M

---22.44M

-Change in other current liabilities

---2.46M

---1.15M

Cash from non-recurring investing activities

Cash from operating activities

---149.40M

---145.83M

Investing cash flow

Net cash from continuing investing activities

--20.83M

--23.42M

Capital expenditures

--20.83M

--23.58M

Net cash flow from disposal of fixed assets

--20.83M

--23.42M

Net cash flow from intangible asset transactions

--0.00

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

---20.83M

---23.42M

Financing cash flow

Cash flow from continuous financing activities

--160.41M

--44.86M

Net cash flow from debt Issuance/repayment

---123.79M

--44.86M

Net cash flow from common stock issuance/repurchase

--284.20M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--160.41M

--44.86M

Net cash flow

Beginning cash balance

--259.91M

--370.37M

Current period cash flow changes

---13.35M

---110.46M

Effect of exchange rate changes

---3.53M

--13.93M

Ending cash balance

--246.55M

--259.91M

Free cash flow

---170.23M

---169.41M

Currency unit

USD

USD

Audit opinions

--

--

KeyAI

